Clinical and molecular diagnosis of pathologic complete response in rectal cancer

Prachi M. Patel, Kelly Harris, Sergio Huerta

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The current standard approach to locally advanced rectal cancer involves pre-operative chemoradiotherapy followed by total mesorectal excision. This practice is supported by several studies that have demonstrated superior local control with this approach. This strategy, leads to a pathologic complete response (pCR) in a substantial proportion of patients treated with neoadjuvant therapy. Furthermore, pCR has been shown to be a reliable predictor of improved oncologic outcomes. This observation has led to an increased interest in the pursuit of identifying clinical, radiographic, pathologic and biochemical predictors of pCR. This review discusses the promising approaches to and most recent advancements in predicting pCR in rectal cancer.

Original languageEnglish (US)
Pages (from-to)1505-1516
Number of pages12
JournalExpert Review of Molecular Diagnostics
Volume15
Issue number11
DOIs
StatePublished - Nov 2 2015

Fingerprint

Rectal Neoplasms
Neoadjuvant Therapy
Chemoradiotherapy

Keywords

  • abdominoperineal resection
  • chemoradiation
  • clinical complete response
  • ionizing radiation
  • low anterior resection
  • lymphocyte to monocyte ratio
  • radiation therapy
  • tumor regression grade

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pathology and Forensic Medicine

Cite this

Clinical and molecular diagnosis of pathologic complete response in rectal cancer. / Patel, Prachi M.; Harris, Kelly; Huerta, Sergio.

In: Expert Review of Molecular Diagnostics, Vol. 15, No. 11, 02.11.2015, p. 1505-1516.

Research output: Contribution to journalArticle

@article{ae690d8cbd5d425a8a3fd6e173c2caaf,
title = "Clinical and molecular diagnosis of pathologic complete response in rectal cancer",
abstract = "The current standard approach to locally advanced rectal cancer involves pre-operative chemoradiotherapy followed by total mesorectal excision. This practice is supported by several studies that have demonstrated superior local control with this approach. This strategy, leads to a pathologic complete response (pCR) in a substantial proportion of patients treated with neoadjuvant therapy. Furthermore, pCR has been shown to be a reliable predictor of improved oncologic outcomes. This observation has led to an increased interest in the pursuit of identifying clinical, radiographic, pathologic and biochemical predictors of pCR. This review discusses the promising approaches to and most recent advancements in predicting pCR in rectal cancer.",
keywords = "abdominoperineal resection, chemoradiation, clinical complete response, ionizing radiation, low anterior resection, lymphocyte to monocyte ratio, radiation therapy, tumor regression grade",
author = "Patel, {Prachi M.} and Kelly Harris and Sergio Huerta",
year = "2015",
month = "11",
day = "2",
doi = "10.1586/14737159.2015.1091728",
language = "English (US)",
volume = "15",
pages = "1505--1516",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "11",

}

TY - JOUR

T1 - Clinical and molecular diagnosis of pathologic complete response in rectal cancer

AU - Patel, Prachi M.

AU - Harris, Kelly

AU - Huerta, Sergio

PY - 2015/11/2

Y1 - 2015/11/2

N2 - The current standard approach to locally advanced rectal cancer involves pre-operative chemoradiotherapy followed by total mesorectal excision. This practice is supported by several studies that have demonstrated superior local control with this approach. This strategy, leads to a pathologic complete response (pCR) in a substantial proportion of patients treated with neoadjuvant therapy. Furthermore, pCR has been shown to be a reliable predictor of improved oncologic outcomes. This observation has led to an increased interest in the pursuit of identifying clinical, radiographic, pathologic and biochemical predictors of pCR. This review discusses the promising approaches to and most recent advancements in predicting pCR in rectal cancer.

AB - The current standard approach to locally advanced rectal cancer involves pre-operative chemoradiotherapy followed by total mesorectal excision. This practice is supported by several studies that have demonstrated superior local control with this approach. This strategy, leads to a pathologic complete response (pCR) in a substantial proportion of patients treated with neoadjuvant therapy. Furthermore, pCR has been shown to be a reliable predictor of improved oncologic outcomes. This observation has led to an increased interest in the pursuit of identifying clinical, radiographic, pathologic and biochemical predictors of pCR. This review discusses the promising approaches to and most recent advancements in predicting pCR in rectal cancer.

KW - abdominoperineal resection

KW - chemoradiation

KW - clinical complete response

KW - ionizing radiation

KW - low anterior resection

KW - lymphocyte to monocyte ratio

KW - radiation therapy

KW - tumor regression grade

UR - http://www.scopus.com/inward/record.url?scp=84947127305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947127305&partnerID=8YFLogxK

U2 - 10.1586/14737159.2015.1091728

DO - 10.1586/14737159.2015.1091728

M3 - Article

C2 - 26415019

AN - SCOPUS:84947127305

VL - 15

SP - 1505

EP - 1516

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 11

ER -